Your browser doesn't support javascript.
loading
Pembrolizumab Plus Axitinib for Metastatic Papillary and Chromophobe Renal Cell Carcinoma: NEMESIA (Non Clear MEtaStatic Renal Cell Carcinoma Pembrolizumab Axitinib) Study, a Subgroup Analysis of I-RARE Observational Study (Meet-URO 23a).
Stellato, Marco; Buti, Sebastiano; Maruzzo, Marco; Bersanelli, Melissa; Pierantoni, Francesco; De Giorgi, Ugo; Di Napoli, Marilena; Iacovelli, Roberto; Vitale, Maria Giuseppa; Ermacora, Paola; Malgeri, Andrea; Maiorano, Brigida Anna; Prati, Veronica; Mennitto, Alessia; Cavo, Alessia; Santoni, Matteo; Carella, Claudia; Fratino, Lucia; Procopio, Giuseppe; Verzoni, Elena; Santini, Daniele.
Afiliación
  • Stellato M; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, 20133 Milano, Italy.
  • Buti S; Department of Medicine and Surgery, University of Parma, 43121 Parma, Italy.
  • Maruzzo M; Medical Oncology Unit, University Hospital of Parma, 43126 Parma, Italy.
  • Bersanelli M; Medical Oncology Unit 1, Department of Oncology, Istituto Oncologico Veneto IOV-IRCCS, 35128 Padua, Italy.
  • Pierantoni F; Medical Oncology Unit, University Hospital of Parma, 43126 Parma, Italy.
  • De Giorgi U; Medical Oncology Unit 3, Department of Oncology, Istituto Oncologico Veneto IOV-IRCCS, 35128 Padua, Italy.
  • Di Napoli M; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, 47014 Meldola, Italy.
  • Iacovelli R; Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, 80131 Napoli, Italy.
  • Vitale MG; Department of Medical Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS Roma, 00168 Roma, Italy.
  • Ermacora P; Medical Oncology, University Hospital Modena, 41121 Modena, Italy.
  • Malgeri A; Department of Oncology, University and General Hospital, 33100 Udine, Italy.
  • Maiorano BA; Department of Medical Oncology, Fondazione Policlinico Campus Bio-Medico, 00128 Roma, Italy.
  • Prati V; Oncology Unit, Foundation Casa Sollievo della Sofferenza IRCCS, 73013 San Giovanni Rotondo, Italy.
  • Mennitto A; Department of Medical Oncology, Ospedale Michele e Pietro Ferrero, Verduno-Azienda Sanitaria Locale CN2, Alba-Bra, 12060 Cuneo, Italy.
  • Cavo A; SCDU Oncologia, "Maggiore della Carità" University Hospital, 28100 Novara, Italy.
  • Santoni M; SSD Oncologia Ospedale Villa Scassi, ASL 3 Genovese, 16149 Genova, Italy.
  • Carella C; Oncology Unit, Macerata Hospital, 62100 Macerata, Italy.
  • Fratino L; SSD Oncologia Medica, IRCCS Istituto Tumori Giovanni Paolo II, 70124 Bari, Italy.
  • Procopio G; Division of Medical Oncology C, Centro di Riferimento Oncologico National Cancer Institute, 33081 Aviano, Italy.
  • Verzoni E; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, 20133 Milano, Italy.
  • Santini D; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, 20133 Milano, Italy.
Int J Mol Sci ; 24(2)2023 Jan 06.
Article en En | MEDLINE | ID: mdl-36674615
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Tipo de estudio: Observational_studies Límite: Humans Idioma: En Revista: Int J Mol Sci Año: 2023 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Tipo de estudio: Observational_studies Límite: Humans Idioma: En Revista: Int J Mol Sci Año: 2023 Tipo del documento: Article País de afiliación: Italia